EBOVAC2
Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II
keywords: IMI projects Infectious diseases Ebola and related diseases Vaccines Ebola+ Conducting clinical trials
- Project website
- http://www.ebovac2.com/
- Start date
- 2014-12-01
- End date
- 2021-05-31
- Funding
- IMI2 - Call 2 (Grant number 115861)
- Types
- IMI projects
